• Je něco špatně v tomto záznamu ?

DNA interstrand cross-linking agents and their chemotherapeutic potential

L. Brulikova, J. Hlavac, P. Hradil,

. 2012 ; 19 (3) : 364-85.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024027

DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024027
003      
CZ-PrNML
005      
20121211210250.0
007      
ta
008      
120815s2012 ne f 000 0#eng||
009      
AR
024    7_
$a 10.2174/092986712803414295 $2 doi
035    __
$a (PubMed)22335513
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Brulíková, Lucie, $d 1980- $7 xx0140920 $u Institute of Molecular and Translational Medicine, Department of Organic Chemistry, Faculty of Science, Palacky University, 17. listopadu 12, 771 46 Olomouc, Czech Republic.
245    10
$a DNA interstrand cross-linking agents and their chemotherapeutic potential / $c L. Brulikova, J. Hlavac, P. Hradil,
520    9_
$a DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed.
650    _2
$a alkaloidy $x chemie $x terapeutické užití $7 D000470
650    _2
$a anthrachinony $x chemie $x terapeutické užití $7 D000880
650    _2
$a antitumorózní látky $x chemie $x terapeutické užití $7 D000970
650    _2
$a azepiny $x chemie $x terapeutické užití $7 D001381
650    _2
$a aziridiny $x chemie $x terapeutické užití $7 D001388
650    _2
$a komplexní sloučeniny $x chemie $x terapeutické užití $7 D056831
650    _2
$a reagencia zkříženě vázaná $x chemie $x terapeutické užití $7 D003432
650    _2
$a DNA $x chemie $x metabolismus $7 D004247
650    _2
$a oprava DNA $7 D004260
650    _2
$a lidé $7 D006801
650    _2
$a mechlorethamin $x chemie $x terapeutické užití $7 D008466
650    _2
$a nádory $x farmakoterapie $7 D009369
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Hlaváč, J
700    1_
$a Hradil, P
773    0_
$w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 19, č. 3 (2012), s. 364-85
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22335513 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121211210333 $b ABA008
999    __
$a ok $b bmc $g 946175 $s 781355
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 19 $c 3 $d 364-85 $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Možnosti archivace